|
[1]LIAW YF.Reversal of cirrhosis:an achievable goal of hepatitis B antiviral therapy[J].J Hepatol, 2013, 59 (4) :880-881.
|
|
[2]MALEKZADEH R, MOHAMADNEJAD M, RAKHSHANI N, et al.Reversibility of cirrhosis in chronic hepatitis B[J].Clin Gastroenterol Hepatol, 2004, 2 (4) :344-347.
|
|
[3]KNODELL RG, ISHAK KG, BLACK WC, et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology, 1981, 1 (5) :431-435.
|
|
[4]SCHEUER PJ.Classification of chronic viral hepatitis:a need for reassessment[J].J Hepatol, 1991, 13 (3) :372-374.
|
|
[5]ISHAK K, BAPTISTA A, BIANCHI L, et al.Histological grading and staging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.
|
|
[6]BEDOSSA P, POYNARD T.An algorithm for the grading of activity in chronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology, 1996, 24 (2) :289-293.
|
|
[7]DIENSTAG JL, GOLDIN RD, HEATHCOTE EJ, et al.Histological outcome during long-term lamivudine therapy[J].Gastroenterology, 2003, 124 (1) :105-117.
|
|
[8]CHANG TT, LIAW YF, WU SS, et al.Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B[J].Hepatology, 2010, 52 (3) :886-893.
|
|
[9]MARCELLIN P, GANE E, BUTI M, et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:a 5-year open-label follow-up study[J].Lancet, 2013, 381 (9865) :468-475.
|
|
[10]D'AMBROSIO R, AGHEMO A, RUMI MG, et al.A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis[J].Hepatology, 2012, 56 (2) :532-543.
|
|
[11] CHEVALLIER M, GUERRET S, CHOSSEGROS P, et al.A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens:comparison with morphometric studies[J].Hepatology, 1994, 20 (2) :349-355.
|
|
[12]KIM SU, OH HJ, WANLESS R, et al.The Laennec staging systemfor histological sub-classification of cirrhosis is useful for stratification of prognosis in pattients with liver cirrhosis[J].J Hepatol, 2012, 57 (3) :556-563.
|
|
[13]BEDOSSA P.Reversibility of hepatitis B virus cirrhosis after therapy:who and why?[J].Liver Int, 2015, 35 (Suppl 1) :78-81.
|
|
[14]TENG XY, ZHOU XG, SUN L, et al.Application of a refined fibrosis staging system to evaluate therapeutic efficacy in chronic viral hepatitis[J].Chin J Hepatol, 2013, 21 (4) :271-274. (in Chinese) 滕晓英, 周新刚, 孙磊, 等.细化慢性肝炎肝纤维化分期标准在药物疗效评定中的应用[J].中华肝脏病杂志, 2013, 21 (4) :271-274.
|
|
[15]JIMENEZ W, PARS A, CABALLERA J, et al.Measurement of fibrosis in needle liver biopsies:evaluation of a colorimetric method[J].Hepatology, 1985, 5 (5) :815-818.
|
|
[16]MANOUSOU P, DHILLON AP, ISGRO G, et al.Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation[J].Liver Transpl, 2011, 17 (2) :178-188.
|
|
[17]TSOCHATZIS E, BRUNO S, ISGRO G, et al.Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis[J].J Hepatol, 2014, 60 (5) :948-954.
|
|
[18]ARIMA M, TERAO H, KASHIMA K, et al.Regression of liver fibrosis in cases of chronic liver disease type C:quantitative evaluation by using computed image analysis[J].Intern Med, 2004, 43 (10) :902-910.
|
|
[19]GOODMAN ZD, BECKER RL Jr, POCKROS PJ, et al.Progression of fibrosis in advanced chronic hepatitis C:evaluation by morphometric image analysis[J].Hepatology, 2007, 45 (4) :886-894.
|
|
[20]O'BRIEN MJ, KEATING NM, ELDERINY S, et al.An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C[J].Am J Clin Pathol, 2000, 114 (5) :712-718.
|
|
[21]WANG Y, HOU JL.Fibrosis assessment:impact on current management of chronic liver disease and application of quantitative invasive tools[J].Hepatol Int, 2016, 10 (3) :448-461.
|
|
[22]XU S, WANG Y, TAI DC, et al.qF ibrosis:a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J].JHepatol, 2014, 61 (2) :260-269.
|
|
[23]WANG Y, HOU JL.Current strategies for quantitating fibrosis in liver biopsy[J].Chin Med J (Engl) , 2015, 128 (2) :252-258.
|
|
[24]WANLESS IR, NAKASHIMA E, SHERMAN M.Regression of human cirrhosis.Morphologic features and the genesis of incomplete septal cirrhosis[J].Arch Pathol Lab Med, 2000, 124 (11) :1599-1607.
|
DownLoad: